gemfibrozil has been researched along with Hepatitis, Chronic in 1 studies
Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basaranoglu, M | 1 |
| Acbay, O | 1 |
| Sonsuz, A | 1 |
1 trial available for gemfibrozil and Hepatitis, Chronic
| Article | Year |
|---|---|
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis.
Topics: Adult; Female; Gemfibrozil; Hepatitis, Chronic; Humans; Hypolipidemic Agents; Liver; Liver Function | 1999 |